What's new

Welcome to sihec | Welcome My Forum

Join us now to get access to all our features. Once registered and logged in, you will be able to create topics, post replies to existing threads, give reputation to your fellow members, get your own private messenger, and so, so much more. It's also quick and totally free, so what are you waiting for?

QurAlis Opens New Global Headquarters

Hoca

Administrator
Staff member
Joined
Apr 6, 2025
Messages
405
Reaction score
0
Points
0
QurAlis opened its new global corporate headquarters in Cambridge, MA. The company’s new 30,000-sq-ft research facility and office space, located at 35 Cambridgepark, doubles QurAlis’ footprint in Alewife Biotech Park.

“Maintaining our corporate headquarters in Cambridge positions us at the heart of a thriving biotechnology hub with world-class talent and leading research institutions,” said Jason Brown, CFO.

“The facility at Alewife allowed us to expand our R&D footprint, lab capacity, and office space, which will continue to foster our mission-driven culture committed to discovering and developing medicines that have the potential to transform the lives of people living with neurodegenerative and neurological diseases.”

QurAlis’ new headquarters offers a larger space with enhanced lab and discovery resources and a 5,000-sq-ft conferencing space for meeting and collaboration. More than one-third of the new facility is dedicated to a 11,000-sq-ft lab with a tissue culture suite and addition of an onsite antisense oligonucleotide (ASO) chemistry manufacturing lab to support programs utilizing QurAlis’ FlexASO® technology platform.

FlexASO was developed to generate splice-switching ASOs with improved potency, increased therapeutic index, and improved bio-distribution. This bespoke platform has the potential to tackle the spectrum of neurodegenerative and neurological diseases.

The post QurAlis Opens New Global Headquarters appeared first on GEN - Genetic Engineering and Biotechnology News.
 
Top Bottom